Market Cap (In CNY)
5.04 Billion
Revenue (In CNY)
541.25 Million
Net Income (In CNY)
27.38 Million
Avg. Volume
697.63 Thousand
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 22.94-66.5
- PE
- -
- EPS
- -
- Beta Value
- 1.554
- ISIN
- CNE100003P82
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Changqing Lin
- Employee Count
- -
- Website
- https://www.hotgen.com.cn
- Ipo Date
- 2019-09-30
- Details
- Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. The company was founded in 2005 and is based in Beijing, China.
More Stocks
-
CPLE5
-
600339
-
VNORPVornado Realty Trust
VNORP
-
HFBA
-
BLUECHIPBlue Chip India Limited
BLUECHIP
-
LOT
-
TOPP
-
MSGCFMAS Gold Corp.
MSGCF